Condition: Achondroplasia · Sponsor: Kyowa Kirin Co., Ltd.
This trial will evaluate the efficacy of KK8398 on annualized height velocity after 52 weeks of repeated administration of KK8398 to patients with achondroplasia
This description comes directly from the study's public registry record.
Kyowa Kirin Co., Ltd. · +81-3-5205-7200 · clinical.info.jp@kyowakirin.com
Always discuss trial participation with your own doctor first.
| Aichi Children's Health and Medical Center | Ōbu, Aichi-ken, Japan | Recruiting |
| Osaka University Hospital | Suita, Osaka, Japan | Recruiting |
| Osaka Women's and Children's Hospital | Waizumi, Osaka, Japan | Recruiting |
| Tokyo Metropolitan Children's Medical Center | Fuchū, Tokyo, Japan | Recruiting |
| Tottori University Hospital | Yonago, Tottori, Japan | Recruiting |
| Niigata University Medical and Dental Hospital | Niigata, Japan | Recruiting |
| Okayama University Hospital | Okayama, Japan | Recruiting |
| ISEIKAI International General Hospital | Osaka, Japan | Recruiting |
| Osaka City General Hospital | Osaka, Japan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06926491